|
1 |
|
Recruiting |
|
Cardiovascular Disease Risk Factors in Chinese
American Immigrants |
|
Conditions: |
|
Hypertension;
Cardiovascular Diseases; Diabetes Mellitus;
Metabolic Syndrome X |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Recruiting |
|
SmartCPR Trial: An Analysis of a Waveform-Based AED
Algorithm on Survival From Out-of-Hospital
Ventricular Fibrillation |
|
Conditions: |
|
Ventricular Fibrillation; Cardiac Arrest |
|
Interventions: |
|
Device: Immediate defibrillation; Device: SmartCPR;
Other: Delayed defibrillation |
|
|
|
|
|
|
|
|
|
3 |
|
Recruiting |
|
A Study of Survivorship Service Capacities Among
Health Care Agencies in New York City |
|
Condition: |
|
All Cancers |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
Recruiting |
|
Psychosocial Support for Cancer Patients |
|
Condition: |
|
Cancer |
|
Interventions: |
|
Behavioral: Dignity Psychotherapy;
Behavioral: Supportive Psychotherapy;
Behavioral: Standard Palliative Care |
|
|
|
|
|
|
|
|
|
5 |
|
Recruiting |
|
Efficacy of Voice Treatment for Parkinson's Disease |
|
Conditions: |
|
Parkinson's Disease;
Dysphagia; Dysarthria |
|
Interventions: |
|
Behavioral: Voice/Respiration Treatment;
Behavioral: Speech/Articulation Treatment;
Behavioral: No intervention (PD);
Behavioral: HC control |
|
1 |
|
Recruiting |
|
Medicinal Plant Use for Treating Inflammation Among
Dominicans in New York City and the Dominican
Republic |
|
|
Condition: |
|
Inflammation |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Recruiting |
|
SmartCPR Trial: An Analysis of a Waveform-Based AED
Algorithm on Survival From Out-of-Hospital
Ventricular Fibrillation |
|
|
Conditions: |
|
Ventricular Fibrillation; Cardiac Arrest |
|
|
Interventions: |
|
Device: Immediate defibrillation;
Device: SmartCPR; Other: Delayed defibrillation |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
Recruiting |
|
A Study of Survivorship Service Capacities Among
Health Care Agencies in New York City |
|
|
Condition: |
|
All Cancers |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
Recruiting |
|
Interpersonal Psychotherapy for Depression in
Pregnancy |
|
|
Conditions: |
|
Major Depression;
Pregnant |
|
|
Intervention: |
|
Behavioral:
Interpersonal Psychotherapy for Antepartum
Depression |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
Recruiting |
|
Outcome Evaluation of Minority AIDS Initiative
Programs in the New York EMA |
|
|
Condition: |
|
HIV Infections |
|
|
Interventions: |
|
Behavioral: Maintenance in Care Services;
Behavioral: Access to Care Services |
|
|
|
|
|
|
|
|
|
|
|
6 |
|
Recruiting |
|
Bone Marrow Cell Transplantation to Improve Heart
Function in Individuals With End-Stage Heart Failure |
|
|
Condition: |
|
Heart Failure, Congestive |
|
|
Interventions: |
|
Procedure: Injection
of immunoselected CD34+ hematopoietic stem cells;
Procedure: Injection of bone marrow mononuclear
cells |
|
|
|
|
|
|
|
|
|
|
|
7 |
|
Recruiting |
|
Intracerebral Clysis in Treating Patients With
Recurrent Primary Brain Tumors |
|
|
Conditions: |
|
Recurrent Anaplastic Astrocytoma;
Recurrent Anaplastic Oligodendroglioma;
Recurrent Anaplastic Oligo-Astrocytoma;
Recurrent Glioblastoma Multiforme |
|
|
Interventions: |
|
Drug: topotecan;
Procedure: Intracerebral Clysis; Procedure: MRI |
|
|
|
|
|
|
|
|
|
|
|
8 |
|
Recruiting |
|
Cardiovascular Disease Risk Factors in Chinese
American Immigrants |
|
|
Conditions: |
|
Hypertension;
Cardiovascular Diseases; Diabetes Mellitus;
Metabolic Syndrome X |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Recruiting |
|
Germline Alterations of Tumor Susceptibility Genes
in New York Cancer Patients |
|
|
Conditions: |
|
Breast Cancer;
Colon Cancer; Prostate Cancer |
|
|
Intervention: |
|
Genetic: PCR/PCR/LDR Strategy |
|
|
|
|
|
|
|
|
|
|
|
10 |
|
Recruiting |
|
Treating Depression With Transcranial Direct Current
Stimulation (tDCS) |
|
|
Condition: |
|
Depression |
|
|
Intervention: |
|
Device: ioMed
Phoresor (transcranial direct current stimulator) |
|
|
|
|
|
|
|
|
|
|
|
11 |
|
Recruiting |
|
Intravitreal Ranibizumab Treatment of Central
Retinal Vein Occlusion With Macular Edema |
|
|
Condition: |
|
Retinal Vein Occlusion |
|
|
Intervention: |
|
Drug: Ranibizumab (Lucentis ) |
|
|
|
|
|
|
|
|
|
|
|
12 |
|
Recruiting |
|
Testing the Effectiveness of VOICES as Implemented
by STD & HIV Prevention Agencies in the US and PR |
|
|
Condition: |
|
Sexually Transmitted Diseases |
|
|
Intervention: |
|
Behavioral: VOICES/VOCES |
|
|
|
|
|
|
|
|
|
|
|
13 |
|
Recruiting |
|
Anti-Psychotic Discontinuation in Alzheimer's
Disease |
|
|
Conditions: |
|
Alzheimer Disease;
Psychotic Disorders |
|
|
Intervention: |
|
Drug: risperidone |
|
|
|
|
|
|
|
|
|
|
|
14 |
|
Recruiting |
|
HIV Prevention Intervention for Couples |
|
|
Condition: |
|
Acquired Immunodeficiency Syndrome |
|
|
Interventions: |
|
Behavioral: Couples HIV counseling and testing;
Behavioral: Women's relationship-focused HIV
counseling and testing |
|
|
|
|
|
|
|
|
|
|
|
15 |
|
Recruiting |
|
Double-Blind, Randomized Study Evaluating the
Efficacy and Safety of Brivaracetam in Adults With
Partial Onset Seizures |
|
|
Condition: |
|
Epilepsy |
|
|
Intervention: |
|
Drug: Brivaracetam |
|
|
|
|
|
|
|
|
|
|
|
16 |
|
Recruiting |
|
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined
With Docetaxel Compared to Docetaxel in Non-Small
Cell Lung Cancer |
|
|
Conditions: |
|
Non-Small Cell Lung Cancer; Lung Cancer |
|
|
Interventions: |
|
Drug: Docetaxel;
Drug: Vandetanib |
|
|
|
|
|
|
|
|
|
|
|
17 |
|
Recruiting |
|
Fludarabine-Based Conditioning for Severe Aplastic
Anemia |
|
|
Condition: |
|
Anemia, Aplastic |
|
|
Interventions: |
|
Drug: Fludarabine;
Drug: Cyclophosphamide |
|
|
|
|
|
|
|
|
|
|
|
18 |
|
Recruiting |
|
Pediatric Residency Training On Tobacco |
|
|
Condition: |
|
Tobacco Use Disorder |
|
|
Intervention: |
|
Behavioral:
Pediatric residency training on tobacco |
|
|
|
|
|
|
|
|
|
|
|
19 |
|
Recruiting |
|
Are Character Building Lessons Effective in
Decreasing Bullying Behaviors? |
|
|
Condition: |
|
Aggression |
|
|
Intervention: |
|
Behavioral: Six
classroom based character building education lessons |
|
|
|
|
|
|
|
|
|
|
|
20 |
|
Recruiting |
|
Collection of Blood for Gene Expression Study in
Individuals With Chronic Lung Diseases |
|
|
Condition: |
|
Pulmonary Diseases |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
21 |
|
Recruiting |
|
A Safety Study of an Oral EGFR Inhibitor, AV-412,
Administered Three Times Weekly in Advanced Solid
Tumor Patients |
|
|
Conditions: |
|
Advanced Cancer;
Refractory Cancer |
|
|
Intervention: |
|
Drug: AV-412 |
|
|
|
|
|
|
|
|
|
|
|
22 |
|
Recruiting |
|
Paroxetine Versus Bupropion for Treating People With
High-Risk Major Depressive Disorder |
|
|
Condition: |
|
Depression |
|
|
Interventions: |
|
Drug: Paxil CR (paroxetine);
Drug: Wellbutrin XL (bupropion) |
|
|
|
|
|
|
|
|
|
|
|
23 |
|
Recruiting |
|
Platelet Activation Markers in Pediatric Cardiac
Surgery |
|
|
Condition: |
|
Coronary Disease |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
|
Recruiting |
|
Combined Exposure Therapy and DCS Vs. Placebo for
PTSD |
|
|
Condition: |
|
Post-Traumatic Stress Disorder |
|
|
Intervention: |
|
Drug: D-Cycloserine |
|
|
|
|
|
|
|
|
|
|
|
25 |
|
Recruiting |
|
Cascade PRFM Study: The Evaluation of Cascade
Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff
Healing |
|
|
Conditions: |
|
Rotator Cuff;
Tendon Injuries |
|
|
Intervention: |
|
Procedure: Placement
of Platelet Rich Fibrin Matrix During Arthroscopic
Rotator Cuff Surgery |
|
|
|
|
|
|
|
|
|
|
|
26 |
|
Recruiting |
|
Acute Myeloid Leukemia T Cell Depletion to Improve
Transplants in Adults With Acute Myeloid Leukemia |
|
|
Condition: |
|
Leukemia, Myelocytic, Acute |
|
|
Intervention: |
|
Procedure: Leukapheresis |
|
|
|
|
|
|
|
|
|
|
|
27 |
|
Recruiting |
|
Trial to Assess Chelation Therapy (TACT) |
|
|
Condition: |
|
Coronary Artery Disease |
|
|
Intervention: |
|
Drug: EDTA chelation therapy |
|
|
|
|
|
|
|
|
|
|
|
28 |
|
Recruiting |
|
Erlotinib or Placebo Following Chemo/RT in Stage III
NSCLC. |
|
|
Conditions: |
|
Carcinoma, Non-Small-Cell Lung;
Non-Small Cell Lung Cancer; NSCLC |
|
|
Intervention: |
|
Drug: erlotinib (tarceva) |
|
|
|
|
|
|
|
|
|
|
|
29 |
|
Recruiting |
|
Respimat Combivent Trial in COPD |
|
|
Condition: |
|
Pulmonary Disease, Chronic Obstructive |
|
|
Interventions: |
|
Drug: Atrovent
Respimat (20 mcg) plus placebo COMBIVENT MDI;
Drug: COMBIVENT MDI (36/206 mcg ) plus placebo
Combivent Respimat; Drug: Combivent Respimat (20
mcg/100 mcg) plus placebo COMBIVENT |
|
|
|
|
|
|
|
|
|
|
|
30 |
|
Recruiting |
|
Targeting INflammation Using SALsalate in Type 2
Diabetes (TINSAL-T2D) |
|
|
Condition: |
|
Type 2 Diabetes |
|
|
Interventions: |
|
Drug: Salsalate;
Drug: Salsalate |
|
|
|
|
|
|
|
|
|
|
|
31 |
|
Recruiting |
|
A Trial in Patients With Diffuse Large-B-Cell
Lymphoma Comparing Pixantrone Against Doxorubicin |
|
|
Condition: |
|
Diffuse Large-Cell Lymphoma |
|
|
Interventions: |
|
Drug: CPOP-R;
Drug: CHOP-R |
|
|
|
|
|
|
|
|
|
|
|
32 |
|
Recruiting |
|
1st or 2nd Line MBC With Previous Avastin Therapy |
|
|
Condition: |
|
Breast Cancer |
|
|
Interventions: |
|
Drug: Gemcitabine;
Drug: Sorafenib; Drug: Placebo |
|
|
|
|
|
|
|
|
|
|
|
33 |
|
Recruiting |
|
A Phase 3 Pivotal Trial Comparing Allovectin-7®
Alone vs Chemotherapy Alone in Patients With Stage 3
or Stage 4 Melanoma |
|
|
Condition: |
|
Metastatic Melanoma |
|
|
Intervention: |
|
Genetic: Allovectin-7® |
|
|
|
|
|
|
|
|
|
|
|
34 |
|
Recruiting |
|
Treatment Options for Type 2 Diabetes in Adolescents
and Youth (TODAY) |
|
|
Condition: |
|
Diabetes Mellitus, Type II |
|
|
Interventions: |
|
Drug: Metformin;
Drug: Rosiglitazone;
Behavioral: TODAY Lifestyle Program |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
Recruiting |
|
Study of Tarceva and Targretin in Stage I-II Lung
Cancer |
|
|
Condition: |
|
Carcinoma, Non-Small-Cell Lung |
|
|
Intervention: |
|
Drug: erlotinib
(Tarceva) and bexarotene (Targretin) |
|
|
|
|
|
|
|
|
|
|
|
36 |
|
Recruiting |
|
A Trial of Pyridoxamine to Lower Urine Oxalate in
Subjects With Stone Disease or Hyperoxaluria |
|
|
Condition: |
|
Kidney Stones |
|
|
Intervention: |
|
Drug: Pyridoxamine |
|
|
|
|
|
|
|
|
|
|
|
37 |
|
Recruiting |
|
Study of the Trifunctional Antibody Catumaxomab to
Treat Recurrent Symptomatic Malignant Ascites |
|
|
Conditions: |
|
Ovarian Neoplasms;
Ascites |
|
|
Intervention: |
|
Drug: catumaxomab |
|
|
|
|
|
|
|
|
|
|
|
38 |
|
Recruiting |
|
Study of Tarceva and Targretin Oral Capsules in
Patients With Advanced Lung Cancer |
|
|
Condition: |
|
Carcinoma, Non-Small-Cell Lung |
|
|
Intervention: |
|
Drug: erlotinib and bexarotene |
|
|
|
|
|
|
|
|
|
|
|
39 |
|
Recruiting |
|
Role of Vascular Endothelial Growth Factor (VEGF) in
Acute Lung Injury/Adult Respiratory Distress
Syndrome (ARDS) |
|
|
Condition: |
|
Respiratory Distress Syndrome, Adult |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
|
Recruiting |
|
Study Evaluating ACC-001 in Mild to Moderate
Alzheimers Disease Subjects |
|
|
Condition: |
|
Alzheimer Disease |
|
|
Interventions: |
|
Drug: arm 1-ACC-001 + QS-21-Active; Drug: ACC-001;
Drug: QS-21-Placebo |
|
|
|
|
|
|
|
|
|
|
|
41 |
|
Recruiting |
|
Study to Investigate Safety and Effectiveness in
Treatment of Insomnia |
|
|
Condition: |
|
Insomnia |
|
|
Intervention: |
|
Drug: Org 50081 |
|
|
|
|
|
|
|
|
|
|
|
42 |
|
Recruiting |
|
A Phase 1 Study of MDV3100 in Patients With
Castration-Resistant (Hormone-Refractory) Prostate
Cancer |
|
|
Conditions: |
|
Prostate Cancer;
Hormone Refractory Prostate Cancer |
|
|
Intervention: |
|
Drug: MDV3100 |
|
|
|
|
|
|
|
|
|
|
|
43 |
|
Recruiting |
|
MIRAGE: Multi-Institutional Research in Alzheimer's
Genetic Epidemiology |
|
|
Condition: |
|
Alzheimer's Disease |
|
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
|
|
44 |
|
Recruiting |
|
Attention Deficit Hyperactivity Disorder (ADHD) in
Adolescents With Substance Use Disorders (SUD) |
|
|
Conditions: |
|
ADHD;
Substance Abuse |
|
|
Intervention: |
|
Drug: Methylphenidate (OROS-MPH) |
|
|
|
|
|
|
|
|
|
|
|
45 |
|
Recruiting |
|
Study to Evaluate the Efficacy and Safety of
Armodafinil as Treatment for Adults With Excessive
Sleepiness Associated With Obstructive Sleep
Apnea/Hypopnea Syndrome With Comorbid Major
Depressive Disorder or Dysthymic Disorder |
|
|
Conditions: |
|
Sleep Disorders;
Obstructive Sleep Apnea;
Major Depressive Disorder; Dysthymic Disorder |
|
|
Interventions: |
|
Drug: armodafinil;
Drug: placebo |
|
|
|
|
|
|
|
|
|
|
|
46 |
|
Recruiting |
|
Gestational Diabetes Mellitus Trial |
|
|
Condition: |
|
Diabetes, Gestational |
|
|
Interventions: |
|
Behavioral: nutritional counseling;
Behavioral: self blood glucose monitoring |
|
|
|
|
|
|
|
|
|
|
|
47 |
|
Recruiting |
|
RCT of Progesterone to Prevent Preterm Birth in
Nulliparous Women With a Short Cervix |
|
|
Conditions: |
|
Preterm Delivery;
Cervical Length |
|
|
Intervention: |
|
Drug: 17 alpha-hydroxyprogesterone caproate |
|
|
|
|
|
|
|
|
|
|
|
48 |
|
Recruiting |
|
A Study of Tanespimycin (KOS-953) in Patients With
Relapsed-Refractory Multiple Myeloma |
|
|
Condition: |
|
Multiple Myeloma |
|
|
Intervention: |
|
Drug: tanespimycin and bortezomib |
|
|
|
|
|
|
|
|
|
|
|
49 |
|
Recruiting |
|
ESCAPE Migraine Trial |
|
|
Conditions: |
|
Migraine Disorders;
Heart Septal Defects, Atrial |
|
|
Intervention: |
|
Device: PFO Closure |
|
|
|
|
|
|
|
|
|
|
|
50 |
|
Not yet
recruiting |
|
IL-1 Trap for Treatment of Familial Mediterranean
Fever (FMF) |
|
|
Condition: |
|
Familial Mediterranean Fever |
|
|
Interventions: |
|
Drug: IL1 Trap (Rilonacept); Drug: Placebo |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51 |
|
Recruiting |
|
Secondary Prevention of Venous Thrombo Embolism. |
|
Condition: |
|
Thromboembolism |
|
Intervention: |
|
Drug: warfarin |
|
|
|
|
|
|
|
|
|
52 |
|
Recruiting |
|
Phase 2 Study of Temozolomide in Pre-Selected
Advanced Aerodigestive Tract Cancers (Study P04273) |
|
Conditions: |
|
Colorectal Neoplasm;
Head and Neck Neoplasm;
Carcinoma, Non-Small-Cell Lung;
Esophageal Neoplasm |
|
Intervention: |
|
Drug: Temozolomide |
|
|
|
|
|
|
|
|
|
53 |
|
Recruiting |
|
Study of Human Monoclonal Antibody to Treat Mycosis
Fungoides and Sezary Syndrome |
|
Conditions: |
|
Mycosis Fungoides;
Sezary Syndrome |
|
Intervention: |
|
Drug: HuMax-CD4 (zanolimumab) |
|
|
|
|
|
|
|
|
|
54 |
|
Not yet
recruiting |
|
Ph I/II Study of Subcutaneously Administered
Veltuzumab (hA20) in NHL and CLL |
|
Conditions: |
|
NHL;
Lymphoma, Non-Hodgkin; Lymphoma, B-Cell;
Lymphoma, Follicular;
Lymphoma, Intermediate-Grade;
Lymphoma, Large-Cell; Lymphoma, Low-Grade;
Lymphoma, Mixed-Cell; Lymphoma, Small-Cell;
Leukemia, Lymphocytic, Chronic;
Leukemia, B-Cell, Chronic;
Leukemia, Prolymphocytic;
Leukemia, Small Lymphocytic;
Lymphoma, Small Lymphocytic;
Lymphoma, Lymphoplasmacytoid, CLL;
Lymphoplasmacytoid Lymphoma, CLL; CLL; SLL |
|
Intervention: |
|
Biological: veltuzumab |
|
|
|
|
|
|
|
|
|
55 |
|
Recruiting |
|
Phase II Study in Patients With Operable Breast
Cancer |
|
Condition: |
|
Breast Cancer |
|
Intervention: |
|
Drug: Pegylated Liposomal Doxorubicin |
|
|
|
|
|
|
|
|
|
56 |
|
Recruiting |
|
A Study of Acyclovir to Help Prevent HIV Infection
in People With Genital Herpes |
|
Conditions: |
|
HIV Infections;
HIV Seronegativity; Herpes Genitalis |
|
Intervention: |
|
Drug: Acyclovir |
|
|
|
|
|
|
|
|
|
57 |
|
Recruiting |
|
SUPARTZ Versus Placebo in Osteoarthritis of the
Shoulder |
|
Condition: |
|
Glenohumeral Osteoarthritis of the Shoulder |
|
Intervention: |
|
Device: SUPARTZ |
|
|
|
|
|
|
|
|
|
58 |
|
Recruiting |
|
Comparing Cognitive Behavioral Therapy,
Antidepressant Medication, and Combined Treatment in
Individuals With Hypochondriasis |
|
Condition: |
|
Hypochondriasis |
|
Interventions: |
|
Drug: Fluoxetine;
Behavioral: Cognitive Behavioral Therapy;
Other: Supportive Therapy; Drug: Placebo |
|
|
|
|
|
|
|
|
|
59 |
|
Recruiting |
|
Predictors of Cognitive Decline in Normal Aging |
|
Conditions: |
|
Alzheimer Disease;
Dementia |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
60 |
|
Recruiting |
|
Biliary Atresia Research Consortium |
|
Conditions: |
|
Biliary Atresia;
Cholestasis |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
61 |
|
Recruiting |
|
Stimulant Versus Nonstimulant Medication for
Attention Deficit Hyperactivity Disorder in Children |
|
Condition: |
|
Attention Deficit Disorder With Hyperactivity |
|
Interventions: |
|
Drug: Atomoxetine;
Drug: Methylphenidate |
|
|
|
|
|
|
|
|
|
62 |
|
Recruiting |
|
Normal Lung Collection: Evaluation of the Lungs of
Normal Individuals With Segmental Bronchopulmonary
Lung Lavage, Bronchial Brushing, and Bronchial Wall
Biopsy |
|
Condition: |
|
Lung Diseases |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
63 |
|
Recruiting |
|
Anti-Pseudomonas Immune Status and Dendritic Cell
Preparation in Normal Individuals |
|
Condition: |
|
Normal Volunteers |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
64 |
|
Recruiting |
|
The Effects of Alendronate After Cure of Primary
Hyperparathyroidism |
|
Condition: |
|
Hyperparathyroidism |
|
Intervention: |
|
Drug: Alendronate |
|
|
|
|
|
|
|
|
|
65 |
|
Recruiting |
|
Varenicline Effects In Schizophrenic Smokers |
|
Conditions: |
|
Schizophrenia;
Tobocco Use Disorder; Nicotine Dependance |
|
Intervention: |
|
Drug: Varenicline |
|
|
|
|
|
|
|
|
|
66 |
|
Recruiting |
|
CT-322 in Treating Patients With Recurrent
Glioblastoma Multiforme and Combination Therapy With
Irinotecan |
|
Condition: |
|
Brain and Central Nervous System Tumors |
|
Interventions: |
|
Drug: CT-322, antiangiogenesis therapy;
Drug: irinotecan hydrochloride |
|
|
|
|
|
|
|
|
|
67 |
|
Recruiting |
|
Evaluating the Genetic Causes and Progression of
Cholestatic Liver Diseases |
|
Conditions: |
|
Liver Diseases;
Alagille Syndrome; Alpha 1-Antitrypsin Deficiency |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
68 |
|
Recruiting |
|
Positive Exposure: A Photography and Video
Intervention for Individuals With Craniofacial
Differences |
|
Condition: |
|
Craniofacial Differences |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
69 |
|
Recruiting |
|
Study of the Clinical Effectiveness of a Human
Monoclonal Antibody to C. Difficile Toxin A and
Toxin B in Patients With Clostridium Difficile
Associated Disease |
|
Condition: |
|
Clostridium Infections |
|
Interventions: |
|
Biological: GS-CDA1;
Biological: MDX-1388; Biological: normal saline |
|
|
|
|
|
|
|
|
|
70 |
|
Recruiting |
|
Inner-City Anti-IgE Therapy for Asthma |
|
Condition: |
|
Asthma |
|
Interventions: |
|
Drug: Omalizumab;
Biological: Standardized asthma care |
|
|
|
|
|
|
|
|
|
71 |
|
Recruiting |
|
RED-HF™ Trial - Reduction of Events With Darbepoetin
Alfa in Heart Failure Trial |
|
Conditions: |
|
Heart Failure;
Anemia; Cardiovascular Disease;
Ventricular Dysfunction; Congestive Heart Failure |
|
Intervention: |
|
Drug: Darbepoetin alfa |
|
|
|
|
|
|
|
|
|
72 |
|
Recruiting |
|
Hormone Therapy With or Without Combination
Chemotherapy in Treating Women Who Have Undergone
Surgery for Node-Negative Breast Cancer (The TAILORx
Trial) |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Drug: anastrozole;
Drug: exemestane; Drug: letrozole;
Drug: tamoxifen citrate;
Procedure: adjuvant therapy;
Procedure: antiestrogen therapy;
Procedure: aromatase inhibition therapy;
Procedure: chemotherapy;
Procedure: cytogenetic analysis;
Procedure: diagnostic procedure;
Procedure: laboratory biomarker analysis;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
73 |
|
Recruiting |
|
ICATA Asthma Mechanistic Study |
|
Condition: |
|
Asthma |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
74 |
|
Recruiting |
|
Sunitinib or Sorafenib in Treating Patients With
Kidney Cancer That Was Removed By Surgery |
|
Condition: |
|
Kidney Cancer |
|
Interventions: |
|
Drug: sorafenib tosylate; Drug: sunitinib malate;
Procedure: adjuvant therapy;
Procedure: antiangiogenesis therapy;
Procedure: conventional surgery;
Procedure: diagnostic procedure;
Procedure: enzyme inhibitor therapy;
Procedure: laboratory biomarker analysis;
Procedure: protein tyrosine kinase inhibitor therapy |
|
|
|
|
|
|
|
|
|
75 |
|
Recruiting |
|
International Immune Tolerance Study |
|
Condition: |
|
Hemophilia A With Inhibitors |
|
Intervention: |
|
Drug: Factor VIII concentrates |
|
|
|
|
|
|
|
|
|
76 |
|
Recruiting |
|
Docetaxel and Prednisone With or Without Bevacizumab
in Treating Patients With Prostate Cancer That Did
Not Respond to Hormone Therapy |
|
Condition: |
|
Prostate Cancer |
|
Interventions: |
|
Drug: bevacizumab;
Drug: docetaxel; Drug: prednisone;
Procedure: antiangiogenesis therapy;
Procedure: chemotherapy;
Procedure: monoclonal antibody therapy |
|
|
|
|
|
|
|
|
|
77 |
|
Recruiting |
|
Zoledronate, Clodronate, or Ibandronate in Treating
Women Who Have Undergone Surgery for Stage I, Stage
II, or Stage III Breast Cancer |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Drug: clodronate disodium;
Drug: ibandronate sodium; Drug: zoledronic acid;
Procedure: adjuvant therapy;
Procedure: bone metastases prevention |
|
|
|
|
|
|
|
|
|
78 |
|
Recruiting |
|
Adjuvant Doxorubicin, Cyclophosphamide, and
Paclitaxel in Treating Patients With Breast Cancer |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Drug: cyclophosphamide;
Drug: doxorubicin hydrochloride; Drug: filgrastim;
Drug: paclitaxel; Drug: pegfilgrastim;
Drug: trastuzumab; Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: colony-stimulating factor therapy;
Procedure: monoclonal antibody therapy |
|
|
|
|
|
|
|
|
|
79 |
|
Recruiting |
|
Dexamethasone Compared With Prednisone During
Induction Therapy and Methotrexate With or Without
Leucovorin During Maintenance Therapy in Treating
Patients With Newly Diagnosed High-Risk Acute
Lymphoblastic Leukemia |
|
Condition: |
|
Leukemia |
|
Interventions: |
|
Drug: cyclophosphamide; Drug: cytarabine;
Drug: daunorubicin hydrochloride;
Drug: dexamethasone;
Drug: doxorubicin hydrochloride;
Drug: leucovorin calcium; Drug: mercaptopurine;
Drug: methotrexate; Drug: pegaspargase;
Drug: prednisone; Drug: thioguanine;
Drug: vincristine; Procedure: chemotherapy;
Procedure: high-dose chemotherapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
80 |
|
Recruiting |
|
Combination Chemotherapy in Treating Young Patients
With Newly Diagnosed Acute Lymphoblastic Leukemia |
|
Condition: |
|
Leukemia |
|
Interventions: |
|
Drug: cyclophosphamide; Drug: cytarabine;
Drug: daunorubicin hydrochloride;
Drug: dexamethasone;
Drug: doxorubicin hydrochloride;
Drug: leucovorin calcium; Drug: mercaptopurine;
Drug: methotrexate; Drug: pegaspargase;
Drug: thioguanine; Drug: vincristine;
Procedure: chemotherapy;
Procedure: intrathecal chemotherapy;
Procedure: radiation therapy;
Procedure: steroid therapy |
|
|
|
|
|
|
|
|
|
81 |
|
Recruiting |
|
Risk-Group Classification of Patients With Newly
Diagnosed Acute Lymphoblastic Leukemia |
|
Condition: |
|
Leukemia |
|
Interventions: |
|
Procedure: DNA ploidy analysis; Procedure: biopsy;
Procedure: chromosomal translocation analysis;
Procedure: diagnostic procedure;
Procedure: fluorescence in situ hybridization;
Procedure: immunologic technique;
Procedure: laboratory biomarker analysis;
Procedure: molecular genetic technique;
Procedure: polymorphism analysis |
|
|
|
|
|
|
|
|
|
82 |
|
Recruiting |
|
Combination Chemotherapy With or Without Gemtuzumab
in Treating Young Patients With Newly Diagnosed
Acute Myeloid Leukemia |
|
Condition: |
|
Leukemia |
|
Interventions: |
|
Drug: anti-thymocyte globulin; Drug: asparaginase;
Drug: busulfan; Drug: cyclophosphamide;
Drug: cyclosporine; Drug: cytarabine;
Drug: daunorubicin hydrochloride; Drug: etoposide;
Drug: gemtuzumab ozogamicin; Drug: methotrexate;
Drug: mitoxantrone hydrochloride;
Procedure: allogeneic bone marrow transplantation;
Procedure: allogeneic hematopoietic stem cell
transplantation; Procedure: chemotherapy;
Procedure: graft versus host disease
prophylaxis/therapy;
Procedure: high-dose chemotherapy;
Procedure: immunoglobulin therapy;
Procedure: intrathecal chemotherapy;
Procedure: monoclonal antibody therapy;
Procedure: umbilical cord blood transplantation |
|
|
|
|
|
|
|
|
|
83 |
|
Recruiting |
|
Epratuzumab and Combination Chemotherapy in Treating
Young Patients With Relapsed Acute Lymphoblastic
Leukemia |
|
Condition: |
|
Leukemia |
|
Interventions: |
|
Drug: asparaginase;
Drug: cyclophosphamide; Drug: cytarabine;
Drug: doxorubicin hydrochloride;
Drug: epratuzumab; Drug: etoposide;
Drug: filgrastim; Drug: leucovorin calcium;
Drug: methotrexate; Drug: pegaspargase;
Drug: prednisone;
Drug: therapeutic hydrocortisone;
Drug: vincristine; Procedure: chemotherapy;
Procedure: colony-stimulating factor therapy;
Procedure: high-dose chemotherapy;
Procedure: monoclonal antibody therapy |
|
|
|
|
|
|
|
|
|
84 |
|
Recruiting |
|
Predictors of Pregnancy Outcome in Systemic Lupus
Erythematosus (SLE) and Antiphospholipid Syndrome
(APS) |
|
Conditions: |
|
Systemic Lupus Erythematosus;
Antiphospholipid Syndrome |
|
Intervention: |
|
|
|
|
|
|
|
|
|
|
|
85 |
|
Recruiting |
|
Radiation Therapy Compared With Chemotherapy and
Radiation Therapy in Treating Patients With Newly
Diagnosed Primary CNS Germ Cell Tumor |
|
Condition: |
|
Brain and Central Nervous System Tumors |
|
Interventions: |
|
Drug: carboplatin;
Drug: cisplatin; Drug: cyclophosphamide;
Drug: etoposide; Drug: filgrastim;
Procedure: chemotherapy;
Procedure: colony-stimulating factor therapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
86 |
|
Recruiting |
|
Treatment for Acute Graft-Versus-Host Disease |
|
Conditions: |
|
Graft vs Host Disease; Immune System Disorders |
|
Interventions: |
|
Drug: Etanercept;
Drug: Mycophenolate Mofeil;
Drug: Denileukin Diftitok; Drug: Pentostatin |
|
|
|
|
|
|
|
|
|
87 |
|
Recruiting |
|
Carboplatin, Paclitaxel, and Pegfilgrastim in
Treating Patients With Stage III or Stage IV Ovarian
Epithelial, Fallopian Tube, Primary Peritoneal, or
Carcinosarcoma Cancer |
|
Conditions: |
|
Fallopian Tube Cancer; Infection; Neutropenia;
Ovarian Cancer; Peritoneal Cavity Cancer |
|
Interventions: |
|
Drug: carboplatin;
Drug: paclitaxel; Drug: pegfilgrastim;
Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: colony-stimulating factor therapy;
Procedure: complications of therapy management;
Procedure: hematologic toxicity attenuation;
Procedure: infection prophylaxis and management |
|
|
|
|
|
|
|
|
|
88 |
|
Recruiting |
|
Comparing Peripheral Blood Stem Cell Transplantation
Versus Bone Marrow Transplantation in Individuals
With Hematologic Cancers |
|
Conditions: |
|
Acute Leukemia;
Chronic Leukemia;
Chronic Myeloproliferative Disorders;
Myelodysplastic and Myeloproliferative Disease |
|
Interventions: |
|
Procedure: allogeneic bone marrow transplantation;
Procedure: peripheral blood stem cell
transplantation |
|
|
|
|
|
|
|
|
|
89 |
|
Recruiting |
|
Comparison of Combination Chemotherapy Regimens With
or Without Cetuximab in Treating Patients Who Have
Undergone Surgery For Stage III Colon Cancer |
|
Condition: |
|
Colorectal Cancer |
|
Interventions: |
|
Drug: cetuximab;
Drug: fluorouracil;
Drug: irinotecan hydrochloride;
Drug: leucovorin calcium; Drug: oxaliplatin;
Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: monoclonal antibody therapy |
|
|
|
|
|
|
|
|
|
90 |
|
Recruiting |
|
Comparison of Two Combination Chemotherapy Regimens
in Treating Women With Breast Cancer |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Drug: cyclophosphamide;
Drug: doxorubicin hydrochloride;
Drug: epirubicin hydrochloride;
Drug: fluorouracil; Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
91 |
|
Recruiting |
|
Letrozole in Treating Postmenopausal Women Who Have
Received Hormone Therapy for Hormone
Receptor-Positive Breast Cancer |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Drug: letrozole;
Procedure: aromatase inhibition therapy |
|
|
|
|
|
|
|
|
|
92 |
|
Recruiting |
|
Radiation Therapy in Treating Women Who Have
Undergone Surgery For Ductal Carcinoma In Situ or
Stage I or Stage II Breast Cancer |
|
Condition: |
|
Breast Cancer |
|
Interventions: |
|
Procedure: adjuvant therapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
93 |
|
Recruiting |
|
Oxaliplatin, Leucovorin, and Fluorouracil With or
Without Bevacizumab in Treating Patients Who Have
Undergone Surgery for Stage II Colon Cancer |
|
Condition: |
|
Colorectal Cancer |
|
Interventions: |
|
Drug: bevacizumab;
Drug: fluorouracil; Drug: leucovorin calcium;
Drug: oxaliplatin; Procedure: adjuvant therapy;
Procedure: antiangiogenesis therapy;
Procedure: chemotherapy;
Procedure: monoclonal antibody therapy |
|
|
|
|
|
|
|
|
|
94 |
|
Recruiting |
|
Carboplatin and Paclitaxel With or Without Sorafenib
in Treating Patients With Unresectable Stage III or
Stage IV Melanoma |
|
Condition: |
|
Melanoma (Skin) |
|
Interventions: |
|
Drug: carboplatin;
Drug: paclitaxel; Drug: sorafenib tosylate;
Procedure: antiangiogenesis therapy;
Procedure: chemotherapy;
Procedure: enzyme inhibitor therapy |
|
|
|
|
|
|
|
|
|
95 |
|
Recruiting |
|
Intensity-Modulated Radiation Therapy to the Pelvis
With or Without Chemotherapy in Treating Patients
With Endometrial Cancer or Cervical Cancer That Has
Been Removed By Surgery |
|
Conditions: |
|
Cervical Cancer;
Endometrial Cancer |
|
Interventions: |
|
Drug: cisplatin;
Procedure: chemotherapy;
Procedure: intensity-modulated radiation therapy |
|
|
|
|
|
|
|
|
|
96 |
|
Recruiting |
|
Single-Fraction Radiation Therapy Compared With
Multiple-Fraction Reirradiation Therapy in Treating
Patients With Painful Bone Metastases |
|
Conditions: |
|
Metastatic Cancer;
Pain |
|
Interventions: |
|
Procedure: pain therapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
97 |
|
Recruiting |
|
Radiation Therapy and Temozolomide in Treating
Patients With Newly Diagnosed Glioblastoma or
Gliosarcoma |
|
Condition: |
|
Brain and Central Nervous System Tumors |
|
Interventions: |
|
Drug: temozolomide;
Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
98 |
|
Recruiting |
|
Radiation Therapy and Cisplatin With or Without
Cetuximab in Treating Patients With Stage III or
Stage IV Head and Neck Cancer |
|
Condition: |
|
Head and Neck Cancer |
|
Interventions: |
|
Drug: cetuximab;
Drug: cisplatin; Procedure: chemotherapy;
Procedure: conventional surgery;
Procedure: monoclonal antibody therapy;
Procedure: radiation therapy;
Procedure: radiosensitization |
|
|
|
|
|
|
|
|
|
99 |
|
Recruiting |
|
Intensity-Modulated Radiation Therapy, Fluorouracil,
and Mitomycin C in Treating Patients With Invasive
Anal Cancer |
|
Condition: |
|
Anal Cancer |
|
Interventions: |
|
Drug: fluorouracil;
Drug: mitomycin C; Procedure: chemotherapy;
Procedure: intensity-modulated radiation therapy |
|
|
|
|
|
|
|
|
|
100 |
|
Recruiting |
|
Single Versus Double Umbilical Cord Blood
Transplantation in Children With High Risk Leukemia
and Myelodysplasia |
|
Conditions: |
|
Acute Myelogenous Leukemia;
Acute Lymphocytic Leukemia;
Chronic Myelogenous Leukemia;
Myelodysplastic Syndrome |
|
Interventions: |
|
Drug: Fludarabine;
Drug: Total Body Irradiation (TBI);
Drug: Cyclophosphamide;
Drug: Mycophenolate Mofetil (MMF);
Drug: Cyclosporine A (CSA) |
|
|
|
|
|
|
|
|
|
151 |
|
Recruiting |
|
Bortezomib With or Without Irinotecan in Treating
Patients With Recurrent or Metastatic Head and Neck
Cancer |
|
|
Condition: |
|
Head and Neck Cancer |
|
|
Interventions: |
|
Drug: bortezomib;
Drug: irinotecan hydrochloride;
Procedure: chemotherapy;
Procedure: enzyme inhibitor therapy |
|
|
|
|
|
|
|
|
|
|
|
152 |
|
Recruiting |
|
Bortezomib in Treating Patients With Advanced Cancer
and Kidney Dysfunction |
|
|
Conditions: |
|
Lymphoma;
Multiple Myeloma and Plasma Cell Neoplasm;
Unspecified Adult Solid Tumor, Protocol Specific |
|
|
Interventions: |
|
Drug: bortezomib;
Procedure: enzyme inhibitor therapy |
|
|
|
|
|
|
|
|
|
|
|
153 |
|
Recruiting |
|
Lenalidomide in Treating Patients Who Are Undergoing
Autologous Stem Cell Transplant for Multiple Myeloma |
|
|
Condition: |
|
Multiple Myeloma and Plasma Cell Neoplasm |
|
|
Interventions: |
|
Drug: cyclophosphamide; Drug: filgrastim;
Drug: lenalidomide; Drug: melphalan;
Procedure: chemotherapy;
Procedure: colony-stimulating factor therapy;
Procedure: high-dose chemotherapy;
Procedure: non-specific immune-modulator therapy;
Procedure: peripheral blood stem cell
transplantation |
|
|
|
|
|
|
|
|
|
|
|
154 |
|
Recruiting |
|
Temozolomide and Radiation Therapy in Treating
Patients With Gliomas |
|
|
Condition: |
|
Brain and Central Nervous System Tumors |
|
|
Interventions: |
|
Drug: temozolomide;
Procedure: adjuvant therapy;
Procedure: chemotherapy;
Procedure: radiation therapy |
|
|
|
|
|
|
|
|
|
|
|
155 |
|
Recruiting |
|
Exemestane in Preventing Cancer in Postmenopausal
Women at Increased Risk of Developing Breast Cancer |
|
|
Condition: |
|
Breast Cancer |
|
|
Interventions: |
|
Drug: exemestane;
Procedure: aromatase inhibition therapy;
Procedure: chemoprevention |
|
|
|
|
|
|
|
|
|
|
|
156 |
|
Recruiting |
|
A Study of Belimumab in Subjects With Systemic Lupus
Erythematosus (SLE) |
|
|
Condition: |
|
Systemic Lupus Erythematosus |
|
|
Interventions: |
|
Drug: belimumab;
Drug: Placebo |
|
|
|
|
|
|
|
|
|
|
|
157 |
|
Recruiting |
|
Carotid Revascularization Endarterectomy Versus
Stenting Trial (CREST) |
|
|
Conditions: |
|
Stroke;
Cerebral Infarction; Carotid Stenosis;
Atherosclerosis |
|
|
Interventions: |
|
Procedure: carotid endarterectomy;
Procedure: carotid angioplasty with stenting |
|
|
|
|
|
|
|
|
|
|
|
158 |
|
Recruiting |
|
Selenium in Preventing Tumor Growth in Patients With
Previously Resected Stage I Non-Small Cell Lung
Cancer |
|
|
Condition: |
|
Lung Cancer |
|
|
Interventions: |
|
Drug: selenium;
Procedure: chemoprevention; Procedure:
preventative nutritional supplementation |
|
|
|
|
|
|
|
|
|
|
|
159 |
|
Recruiting |
|
Comparison of Two Salvage Chemotherapy Regimens
Before Autologous Stem Cell Transplantation With or
Without Maintenance Rituximab in Treating Patients
With Relapsed or Refractory Aggressive Non-Hodgkin's
Lymphoma |
|
|
Condition: |
|
Lymphoma |
|
|
Interventions: |
|
Drug: cisplatin;
Drug: cytarabine; Drug: dexamethasone;
Drug: gemcitabine hydrochloride; Drug: rituximab;
Procedure: autologous bone marrow transplantation;
Procedure: chemotherapy;
Procedure: high-dose chemotherapy;
Procedure: monoclonal antibody therapy; Procedure:
peripheral blood stem cell transplantation |
|
|
|
|
|
|
|
|
|
|
|
160 |
|
Recruiting |
|
Rosiglitazone (Extended Release Tablets) As
Adjunctive Therapy In Subjects With Mild To Moderate
Alzheimer's Disease |
|
|
Condition: |
|
Alzheimer's Disease |
|
|
Intervention: |
|
Drug: Rosiglitazone
XR (extended release) oral tablets |
|
|
|
|
|
|
|
|
|
|
|
161 |
|
Recruiting |
|
Irinotecan and Temozolomide in Treating Young
Patients With Recurrent Neuroblastoma |
|
|
Condition: |
|
Neuroblastoma |
|
|
Interventions: |
|
Drug: irinotecan hydrochloride;
Drug: temozolomide; Procedure: chemotherapy |
|
|
|
|
|
|
|
|
|
|
|
162 |
|
Recruiting |
|
A Comparison of AZD6140 and Clopidogrel in Patients
With Acute Coronary Syndrome |
|
|
Condition: |
|
Acute Coronary Syndrome |
|
|
Interventions: |
|
Drug: AZD6140;
Drug: Clopidogrel |
|
|
|
|
|
|
|
|
|
|
|
163 |
|
Recruiting |
|
Natural History Study of Infants With Adrenal Masses
Found on Prenatal and/or Neonatal Imaging |
|
|
Conditions: |
|
Adrenocortical Carcinoma; Neuroblastoma;
Precancerous/Nonmalignant Condition |
|
|
Interventions: |
|
Procedure: computed tomography;
Procedure: diagnostic procedure;
Procedure: magnetic resonance imaging |
|
|
|
|
|
|
|
|
|
|
|
164 |
|
Recruiting |
|
Letrozole After Tamoxifen in Treating Women With
Breast Cancer |
|
|
Condition: |
|
Breast Cancer |
|
|
Interventions: |
|
Drug: letrozole;
Procedure: aromatase inhibition therapy |
|
|
|
|
|
|
|
|
|
|
|
165 |
|
Recruiting |
|
Cisplatin and Radiation Therapy With or Without
Tirapazamine in Treating Patients With Cervical
Cancer |
|
|
Condition: |
|
Cervical Cancer |
|
|
Interventions: |
|
Drug: cisplatin;
Drug: tirapazamine; Procedure:
chemosensitization/potentiation therapy;
Procedure: chemotherapy;
Procedure: radiation brachytherapy;
Procedure: radiation therapy;
Procedure: radiosensitization |
|
|
|
|
|
|
|
|
|
|
|
166 |
|
Recruiting |
|
Anastrozole With or Without Fulvestrant as
First-Line Therapy in Treating Postmenopausal Women
With Metastatic Breast Cancer |
|
|
Condition: |
|
Breast Cancer |
|
|
Interventions: |
|
Drug: anastrozole;
Drug: fulvestrant;
Procedure: antiestrogen therapy;
Procedure: aromatase inhibition therapy |
|
|
|
|
|
|
|
|
|
|
|
167 |
|
Recruiting |
|
Rosiglitazone (Extended Release Tablets) Monotherapy
In Subjects With Mild To Moderate Alzheimer's
Disease |
|
|
Condition: |
|
Alzheimer's Disease |
|
|
Intervention: |
|
Drug: Rosiglitazone
XR (extended release) oral tablets |
|
|
|
|
|
|
|
|
|
|
|
168 |
|
Recruiting |
|
Surgery and Combination Chemotherapy in Treating
Children With Extracranial Germ Cell Tumors |
|
|
Conditions: |
|
Childhood Germ Cell Tumor;
Extragonadal Germ Cell Tumor; Ovarian Cancer |
|
|
Interventions: |
|
Drug: bleomycin;
Drug: cisplatin; Drug: etoposide;
Procedure: chemotherapy;
Procedure: conventional surgery |
|
|
|
|
|
|
|
|
|
|
|
169 |
|
Recruiting |
|
Safety and Effectiveness of 3 Doses of Crofelemer
Compared to Placebo in the Treatment of HIV
Associated Diarrhea |
|
|
Conditions: |
|
